Neogen (NEOG) Stock
Food and animal safety testing specialist for regulated industries. Here's the price, business snapshot, and what's worth knowing about Neogen in June 2026.
Neogen Corporation (NEOG) supplies testing, products and services aimed at food and animal safety. The company sells diagnostic kits, sanitising and lab equipment, veterinary instruments and related consumables to food processors, retailers and animal-health customers. With a market capitalisation around $1.28bn, Neogen operates in a specialist niche where regulatory standards, outbreak prevention and quality assurance drive demand. Growth has come from product development and selective acquisitions, giving scale in both testing technologies and consumables. Investors should note the business can be cyclical with exposure to food-industry spending and margins influenced by raw‑material and integration costs. This summary is general educational information, not personalised advice — stocks can fall as well as rise, and suitability depends on your financial situation and risk tolerance.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying NEOGEN Corp's stock, expecting it to rise significantly in value.
Financial Health
NEOGEN Corp shows solid revenue and profit generation, indicating a healthy financial performance.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Discover More Opportunities
Abbott
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
AGILENT TECHNOLOGIES INC
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.
ALIGN TECHNOLOGY INC
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
Baskets Featuring NEOG
Food Safety Stocks: What's Next After Costco Lawsuit
A recent lawsuit against Costco regarding salmonella in its rotisserie chicken has intensified focus on food safety across the grocery industry. This creates a potential investment opportunity in companies that provide testing, diagnostics, and supply chain verification services.
Published: 15 February 2026
Explore BasketFood Safety Investing: The Next Chapter Unfolds
Recent recalls of baby formula by Danone and other major brands, traced back to a single contaminated ingredient supplier, have exposed significant risks in the global supply chain. This situation creates a potential investment opportunity in companies focused on food safety, testing, and alternative brands with more secure sourcing.
Published: 24 January 2026
Explore BasketNext-Gen Proteins
Looking to invest in the future of food? This carefully selected group of stocks represents companies solving our global protein challenges. From plant-based alternatives to agricultural innovation, these stocks have been thoughtfully chosen by our analysts for their potential in this growing market.
Published: 17 June 2025
Explore BasketWhy You’ll Want to Watch This Stock
Recurring Consumables Demand
A sizeable portion of sales are repeat consumables and reagents, which can provide revenue durability — though volumes may vary with industry spending.
Regulation Supports Need
Tighter food‑safety rules and globalisation of supply chains can increase demand for testing and traceability, yet regulatory shifts can also change buyer behaviour.
Product & Acquisition Strategy
Neogen grows through new diagnostics and selective acquisitions that expand capabilities and distribution, but integration and margin effects warrant attention.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
